Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s wholly owned subsidiary is Alaric Corporation.


OTCPK:HALB - Post by User

<< Previous
Bullboard Posts
Next >>
Post by AveragePennyon Apr 29, 2022 12:39pm
39 Views
Post# 34642736

Dr. Gregg Sturrus' TEDx Talk(R) Features Halberd's Extracorp

Dr. Gregg Sturrus' TEDx Talk(R) Features Halberd's Extracorp

JACKSON CENTER, PA / ACCESSWIRE / April 29, 2022 / A key member of Halberd Corporation's (OTC PINK:HALB) Research Team, Dr. W. Gregg Sturrus, recently gave a TEDx Talk® on Halberd's patented and patent-pending extracorporeal elimination of neurodegenerative disease proteins and cytokines using lasers and metallic nanoparticles. The video can be found herehttps://www.youtube.com/watch?v=Tfl2x7t4FHo

Dr. Sturrus, in his talk, provided a brief history of the evolution of the technology and outlines the innovative Halberd approach to potentially treating neurodegenerative diseases, as well as other diseases.

Dr. Sturrus is Chair of the Physics, Astronomy, Geology and Earth Sciences department at Youngstown State University. Dr. Sturrus has over 30 years of experience in the areas of atomic physics, radio frequency and laser research.

To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.

https://www.accesswire.com/699392/dr-gregg-sturrus-tedx-talkr-features-halberds-extracorporeal-treatment-of-neurodegenerative-diseases

<< Previous
Bullboard Posts
Next >>